(a) Dimensionless diameter and (b) droplet generation frequency versus the magnet distance from the vertex of the hydrophilic surface for different ferrofluid injection rates and t... by Amirhossein Favakeh (21417884)

Subjects:

The Fig illustrates the effects of mutations on the stability, flexibility, compactness, and interactions of the AKT2-Akt1/Akt2-IN-1 through molecular dynamics simulations. by Sadia Afrin Runa (22504971)

Subjects:

S1 File - Utilization of psychotropic drugs in Serbia from 2006 to 2021: Patterns before and during the COVID-19 pandemic by Jelena Filimonovic (22305307)

Subjects:

S1 Data - by Richard Junior Zapata Dongo (17912565)

“…This interaction was further supported by a significant decrease of ALK phosphorylation in single and combination treatment with 300nM ABT-199. …”

Multiomics Approach Identifies Key Proteins and Regulatory Pathways in Colorectal Cancer by Jun Rao (2031019)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Mechanistically, compound <b>E35</b> markedly decreased the expression of Skp2, as well as increased the expression of its substrates p21 and p27. …”

Effect of CD8+ T-cells coculture and CM on hypoxic and normoxic PANC-1 cells. by Eiman Abdo (20642254)

Subjects:

CFSE staining of CD8+ T-cells for proliferation assessment. by Eiman Abdo (20642254)

Subjects:

Percentages (%) of concentration changes in TNF-α, IL-6, and IFN-γ released by PANC-1 cells under hypoxic and normoxic conditions cultured with CD8+ T-cells CM. by Eiman Abdo (20642254)

Subjects:

CD8+ T-cells percentage in PBMCs and purity after isolation and activation. by Eiman Abdo (20642254)

Subjects:

Assessment of CD8+ T-cells viability after activation and culturing in HCM vs. NCM for 72 hours by staining with 7-AAD. by Eiman Abdo (20642254)

Subjects:

Percentages of concentration changes in TNF-α, IL-6, and IFN-γ in co-culture of hypoxic and normoxic PANC-1 cells with CD8+ T-cells. by Eiman Abdo (20642254)

Subjects:

Relative expression levels in TNF-α, IL-6, and p53 in co-culture and CM treatment of hypoxic and normoxic PANC-1 cells with CD8+ T-cells. by Eiman Abdo (20642254)

Subjects:

Percentages (%) of concentration changes of cytokines for CD8+ T-cells after cultured in HCM or NCM of PANC-1 cells. by Eiman Abdo (20642254)

Subjects:

Measurement of inflammatory cytokines in liver and heart tissues. by Ayça Toprak-Semiz (22582110)

Subjects:

Comparison results for median (25th percentile-75th percentile) damage degree scores for liver and heart tissues. by Ayça Toprak-Semiz (22582110)

Subjects: